Candel Therapeutics (CADL)

• Market cap: $312M
• 1 day: 5.37%
• 5 days: 5.18%
• 1 month: 5.37%
• 3 months: -17.06%
• 6 months: 14.49%
• Year to date: -36.71%
• 1 year: 3.27%
• 5 years: -18.71%
• 10 years: -18.71%
• Sector: Healthcare
• Industry: Biotechnology

About: Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Employees: 38